Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13

BRIDGEWATER, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, will attend the 12th Annual World Orphan Drug Congress USA 2022, being held at the Hynes Convention Center in Boston, on July 11-13, 2022.

Go here to see the original:
Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13